A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Clinical trial NCT05144984 · COMPLETED
Trial details
- NCT number
- NCT05144984
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2023-02-13
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.